Accelerated Discovery of Novel Ponatinib Analogs with Improved Properties for the Treatment of Parkinson's Disease (vol 11, pg 491, 2020)

被引:0
作者
Kaiser, Thomas M.
Dentmon, Zackery W.
Dalloul, Christopher E.
Sharma, Savita K.
Liotta, Dennis C.
机构
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 07期
关键词
D O I
10.1021/acsmedchemlett.0c00336
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1491 / 1491
页数:1
相关论文
共 50 条
  • [21] Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease (vol 143, pg 2757, 2020)
    Biondetti, Emma
    Gaurav, Rahul
    Yahia-Cherif, Lydia
    Mangone, Graziella
    Pyatigorskaya, Nadya
    Valabregue, Romain
    Ewenczyk, Claire
    Hutchison, Matthew
    Francois, Chantal
    Arnulf, Isabelle
    Corvol, Jean-Christophe
    Vidailhet, Marie
    Lehericy, Stephane
    BRAIN, 2021, 144
  • [22] Feasibility of Smartphone-Based Gait Assessment for Parkinson's Disease (vol 40, pg 582, 2020)
    Tang, Shih-Tsang
    Tai, Chun-Hwei
    Yang, Chia-Yen
    Lin, Jiun-Hung
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2020, 40 (05) : 770 - 771
  • [23] Defective corticomuscular connectivity during walking in patients with Parkinson's disease (vol 124, pg 1399, 2020)
    Yokoyama, H.
    Yoshida, T.
    Zabjek, K.
    Chen, R.
    Masani, K.
    JOURNAL OF NEUROPHYSIOLOGY, 2020, 124 (06) : 2076 - 2076
  • [24] Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma (vol 79, pg 1327, 2020)
    Khan, Mostafa J.
    Desaire, Heather
    Lopez, Oscar L.
    Kamboh, M. Ilyas
    Robinson, Rena A. S.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (04) : 1739 - 1739
  • [25] Targeting the subthalamic nucleus in the treatment of Parkinson's disease (vol 46, pg 467, 1997)
    Henderson, JM
    Dunnett, SB
    BRAIN RESEARCH BULLETIN, 1998, 47 (02) : 193 - 193
  • [26] Levodopa in the treatment of Parkinson's disease: Current controversies (vol 19, pg 997, 2004)
    Olanow, CW
    Agid, Y
    Mizuno, Y
    Albanese, A
    Bonuccelli, U
    Damier, P
    De Yebenes, J
    Gershanik, O
    Guttman, M
    Grandas, F
    Hallett, M
    Hornykiewicz, O
    Jenner, P
    Katzenschlager, R
    Langston, WJ
    LeWitt, P
    Melamed, E
    Mena, MA
    Michel, PP
    Mytilineou, C
    Obeso, JA
    Poewe, W
    Quinn, N
    Raisman-Vozari, R
    Rajput, AH
    Rascol, O
    Sampaio, C
    Stocchi, F
    MOVEMENT DISORDERS, 2005, 20 (05) : 645 - 645
  • [27] Brain iron deposition is linked with cognitive severity in Parkinson's disease (vol 91, pg 418, 2020)
    Thomas, G. E. C.
    Leyland, L. A.
    Schrag, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (05) : E2 - E2
  • [28] Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease (vol 143, pg 2757, 2020)
    Biondetti, Emma
    Gaurav, Rahul
    Yahia-Cherif, Lydia
    Mangone, Graziella
    Pyatigorskaya, Nadya
    Valabregue, Romain
    Ewenczyk, Claire
    Hutchison, Matthew
    Francois, Chantal
    Arnulf, Isabelle
    Corvol, Jean-Christophe
    Vidailhet, Marie
    Lehericy, Stephane
    BRAIN, 2021, 144 (02)
  • [29] Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (vol 11, 849, 2020)
    Chao, Yin-Xia
    Gulam, Muhammad Yaaseen
    Chia, Nicholas Shyh Jenn
    Feng, Lei
    Rotzschke, Olaf
    Tan, Eng-King
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [30] Neural Correlates of Freezing of Gait in Parkinson's Disease: An Electrophysiology Mini-Review (vol 11, 571086, 2020)
    Marquez, J. Sebastian
    Hasan, S. M. Shafiul
    Siddiquee, Masudur R.
    Luca, Corneliu C.
    Mishra, Virendra R.
    Mari, Zoltan
    Bai, Ou
    FRONTIERS IN NEUROLOGY, 2022, 13